anonymous
Guest
anonymous
Guest
Lilly, Novo, Astra, Novartis, Merck all trading at or near 52 weeks highs. GSK trading at near 10 year lows. Help me understand how Emma still has a job.
Lilly, Novo, Astra, Novartis, Merck all trading at or near 52 weeks highs. GSK trading at near 10 year lows. Help me understand how Emma still has a job.
Emma and her team presented a 5 and 10 year plan to turn around GSK.
did the GSK 10 year plan say “sit on our hands for the first five years”?
AZ was and is ambitious; making BD and acquiring big assets and deals that brigs more revenue- what is GSK’s ambition¿
didn’t we all listen and allow Hal B to make those big investments… that non of them paid off!
didn’t we all listen and allow Hal B to make those big investments… that non of them paid off!
didn’t we all listen and allow Hal B to make those big investments… that non of them paid off!
The body consists of a complex network of chemical reaction chains, with transport mechanisms, converters, buffers, filters, sinks, sources and whatnot. Most functions have several backups. They all have individual states with hundreds of relevant values, change heavily within days, even hours.
So a working treatment will mostly be a complex lifestyle & drug regime, involve regular sensitivity analysis, high end control theory. It will often be about the limits of reversibility.
Didn’t Emma pay Hal more than her and fund an expense account of over $1m per year?
He really did ride the gravy train and GSK kept him on the books as a non-Exec Director and member of the science committee …. Yeah, getting ahead of disease together
How did he ever get away with the travel expenses and his lack of action in his role? Sound like a real high quality individual.
Lilly, Novo, Astra, Novartis, Merck all trading at or near 52 weeks highs. GSK trading at near 10 year lows. Help me understand how Emma still has a job.
Emma and her team presented a 5 and 10 year plan to turn around GSK. When you step into an organization with less than a full cabinet of products trends don't change overnight.
It wasn't to long ago AZ was a company with shelves half full. Seems AZ has now turned it around and that didn't happen overnight.
So it only seems fair that Emma is given her chance to prove she can get this company back to respectability over the next 5-6 years. Like it or not that will be the case.